Last reviewed · How we verify
Volulyte 6%
At a glance
| Generic name | Volulyte 6% |
|---|---|
| Also known as | Hydroxyethyl starch 130/0.4, Hydroxyethyl starch 130 |
| Sponsor | Fresenius Kabi |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Hydroxyethyl Starch Versus Crystalloid and Postoperative Major Adverse Kidney Complications (PHASE4)
- Safety and Efficacy of Perioperative Volume Replacement with Volulyte 6% in Moderate-to-high Cardiovascular Risk Patients Having Major Abdominal Surgery (PHASE4)
- Safety and Efficacy of 6% Hydroxyethyl Starch (HES) Solution Versus an Electrolyte Solution in Patients Undergoing Elective Abdominal Surgery (PHASE4)
- Safety and Efficacy of a 6% Hydroxyethyl Starch (HES) Solution Versus an Electrolyte Solution in Trauma Patients (PHASE4)
- Colloids in Pediatric Cardiac Surgery: Comparison Between a Balanced and a Non-balanced Colloid (PHASE3)
- Combination of Static Echocardiographic Indices for Prediction of Fluid Responsiveness During Cardiac Surgery
- Crystalloid Versus Colloid Rapid Co-load for Cesarean Delivery Under Spinal Anesthesia (NA)
- The Use of Tidal Volume Challenge of Dynamic Parameters During Laparoscopic Surgery
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |